These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35503884)

  • 1. A Case of Tofacitinib-Induced Lymphomatoid Papulosis With Ocular Involvement.
    Knapp C; Steele E; Mengden-Koon S; Williams T; Fett N
    Am J Dermatopathol; 2022 Jul; 44(7):523-525. PubMed ID: 35503884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Oral involvement in lymphomatoid papulosis].
    Serra-Guillén C; Requena C; Alfaro A; Hueso L; Sanmartín O; Llombart B; Nagore E; Botella-Estrada R; Martorell-Calatayud A; Guillén C
    Actas Dermosifiliogr; 2007 May; 98(4):265-7. PubMed ID: 17506958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphomatoid papulosis and cutaneous CD30+ lymphoma.
    LeBoit PE
    Am J Dermatopathol; 1996 Jun; 18(3):221-35. PubMed ID: 8806956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of a patient with lymphomatoid papulosis by methotrexate.
    Yazawa N; Kondo S; Kagaya M; Yazawa H; Minamitsuji Y; Jimbow K
    J Dermatol; 2001 Jul; 28(7):373-8. PubMed ID: 11510505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tofacitinib Treatment of Refractory Cutaneous Leukocytoclastic Vasculitis: A Case Report.
    Zhu KJ; Yang PD; Xu Q
    Front Immunol; 2021; 12():695768. PubMed ID: 34248994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitrogen mustard gel-induced inflammation triggers lymphomatoid papulosis in patients with mycosis fungoides.
    Trager MH; Chen C; Husain S; Geskin LJ
    J Dermatol; 2020 May; 47(5):546-550. PubMed ID: 32100361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An unusual case of lymphomatoid papulosis type E with extensive necrosis.
    Pindado-Ortega C; Fonda-Pascual P; Buendía-Castaño D; Fernández-González P; Peña-Jaimes L; Carrillo-Gijón R
    Indian J Dermatol Venereol Leprol; 2018; 84(4):515-517. PubMed ID: 29067932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphomatoid papulosis: a clinical case.
    Sass U; Shahabpour M; André J; Ledoux M
    Dermatology; 1995; 190(4):327-9. PubMed ID: 7655118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphomatoid papulosis associated with both severe hypereosinophilic syndrome and CD30 positive large T-cell lymphoma.
    Granel B; Serratrice J; Swiader L; Horshowski N; Blaise D; Vey N; Metras D; Habib G; Disdier P; Weiller PJ
    Cancer; 2000 Nov; 89(10):2138-43. PubMed ID: 11066056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphomatoid papulosis associated with pregnancy.
    Yamamoto O; Tajiri M; Asahi M
    Clin Exp Dermatol; 1997 May; 22(3):141-3. PubMed ID: 9425694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two cases of lymphomatoid papulosis in children.
    Aoki E; Aoki M; Kono M; Kawana S
    Pediatr Dermatol; 2003; 20(2):146-9. PubMed ID: 12657013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD30 antigen expression in cutaneous inflammatory infiltrates of scabies: a dynamic immunophenotypic pattern that should be distinguished from lymphomatoid papulosis.
    Gallardo F; Barranco C; Toll A; Pujol RM
    J Cutan Pathol; 2002 Jul; 29(6):368-73. PubMed ID: 12135469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of clinical, morphological and immunohistochemical features of lymphomatoid papulosis and primary cutaneous CD30(Ki-1)-positive anaplastic large cell lymphoma.
    Tomaszewski MM; Lupton GP; Krishnan J; May DL
    J Cutan Pathol; 1995 Aug; 22(4):310-8. PubMed ID: 7499570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphomatoid papulosis subtype C: A case report and literature review.
    Wang L; Chen F; Zhao S; Wang X; Fang J; Zhu X
    Dermatol Ther; 2021 Jan; 34(1):e14452. PubMed ID: 33099866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphomatoid papulosis: A cutaneous lymphoproliferative disorder in a patient on fingolimod for multiple sclerosis.
    Samaraweera AP; Cohen SN; Akay EM; Evangelou N
    Mult Scler; 2016 Jan; 22(1):122-4. PubMed ID: 26219664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphomatoid papulosis with a natural killer-cell phenotype.
    Bekkenk MW; Kluin PM; Jansen PM; Meijer CJ; Willemze R
    Br J Dermatol; 2001 Aug; 145(2):318-22. PubMed ID: 11531801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical methotrexate for lymphomatoid papulosis.
    Bergstrom JS; Jaworsky C
    J Am Acad Dermatol; 2003 Nov; 49(5):937-9. PubMed ID: 14576686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lymphomatoid papulosis in a child].
    Léauté-Labrèze C; Bioulac-Sage P; Belleannée G; Merlio JP; Vergnes P; Maleville J; Taïeb A
    Arch Pediatr; 1995 Oct; 2(10):984-7. PubMed ID: 7496478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angioinvasive lymphomatoid papulosis: another case of a newly described variant.
    Sharaf MA; Romanelli P; Kirsner R; Miteva M
    Am J Dermatopathol; 2014 Mar; 36(3):e75-7. PubMed ID: 23863551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders.
    Vonderheid EC; Sajjadian A; Kadin ME
    J Am Acad Dermatol; 1996 Mar; 34(3):470-81. PubMed ID: 8609262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.